Personalised Medicine: Multidisciplinary Research Towards IM

01.03.2020 - 30.11.2023
Forschungsförderungsprojekt

Prostate cancer (PCa) is the most frequent diagnosed malignancy in male patients and radiation therapy (RT) is a main treatment option. However, RT concepts for PCa have an imminent need to be rectified in order to personalise the RT strategy by considering (i) the individual PCa biology and (ii) the individual disease process of each patient. The consortium concatenates a prospective, nonrandomized phase II trial for personalised RT of PCa patients (HypoFocal) with novel tools for patient involvement, advanced “omic” and bioinformatical analyses. Hereby, the implementation of novel computational components enables (i) unbiased characterisation of tumor and normal tissue biology for personalised treatment planning processes (ii) direct integration of patients’ preferences for a personalised treatment planning and follow-up process after RT.

Personen

Projektleiter_in

Subprojektleiter_in

Institut

Grant funds

  • FWF - Österr. Wissenschaftsfonds (National) Stand-Alone Project Austrian Science Fund (FWF)

Forschungsschwerpunkte

  • Computer Engineering and Software-Intensive Systems: 100%

Schlagwörter

DeutschEnglisch
Prostate cancerpersonalised RT

Externe Partner_innen

  • Technical University Athens
  • Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany
  • Hellenic Cooperative Oncology Group
  • IRCCS Humanitas

Publikationen